BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31364369)

  • 1. Considerations for use of ketamine to treat depression in Australia and New Zealand.
    Bayes A; Dong V; Loo C
    Aust N Z J Psychiatry; 2019 Nov; 53(11):1117-1120. PubMed ID: 31364369
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketamine for treatment-resistant depression: ready or not for clinical use?
    Rush AJ
    Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ketamine--a new treatment option for therapy-resistant depression].
    Köhler S; Betzler F
    Fortschr Neurol Psychiatr; 2015 Feb; 83(2):91-7. PubMed ID: 25723773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage.
    Scheele D; Zimbal S; Feinstein JS; Delis A; Neumann C; Mielacher C; Philipsen A; Hurlemann R
    Am J Psychiatry; 2019 Dec; 176(12):982-986. PubMed ID: 31787017
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketamine as an alternative treatment for treatment-resistant depression.
    Dowben JS; Grant JS; Keltner NL
    Perspect Psychiatr Care; 2013 Jan; 49(1):2-4. PubMed ID: 23293991
    [No Abstract]   [Full Text] [Related]  

  • 6. A word to the wise about ketamine.
    Schatzberg AF
    Am J Psychiatry; 2014 Mar; 171(3):262-4. PubMed ID: 24585328
    [No Abstract]   [Full Text] [Related]  

  • 7. Riluzole likely lacks antidepressant efficacy in ketamine non-responders.
    Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Ballard ED; Brutsche NE; Furey ML; Zarate CA
    J Psychiatr Res; 2014 Nov; 58():197-9. PubMed ID: 25139008
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-dose ketamine followed by daily D-Cycloserine in treatment-resistant bipolar depression.
    Kantrowitz JT; Halberstam B; Gangwisch J
    J Clin Psychiatry; 2015 Jun; 76(6):737-8. PubMed ID: 26132675
    [No Abstract]   [Full Text] [Related]  

  • 9. Electroconvulsive therapy is a standard treatment; ketamine is not (yet).
    Kellner CH; Greenberg RM; Ahle GM; Liebman LS
    Am J Psychiatry; 2014 Jul; 171(7):796. PubMed ID: 24980176
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketamine for chronic depression: two cautionary tales.
    Talbot J; Phillips JL; Blier P
    J Psychiatry Neurosci; 2019 Nov; 44(6):384-385. PubMed ID: 31573153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
    Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
    J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
    [No Abstract]   [Full Text] [Related]  

  • 12. Ketamine for Treatment-Resistant bipolar depression-A reality check!
    Singh B
    Bipolar Disord; 2023 May; 25(3):247-248. PubMed ID: 36978284
    [No Abstract]   [Full Text] [Related]  

  • 13. Ketamine for Treatment-Resistant Depression: a New Advocate.
    Pérez-Esparza R
    Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA antagonist treatment of depression.
    Williams NR; Schatzberg AF
    Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study.
    Domany Y; Bleich-Cohen M; Tarrasch R; Meidan R; Litvak-Lazar O; Stoppleman N; Schreiber S; Bloch M; Hendler T; Sharon H
    Br J Psychiatry; 2019 Jan; 214(1):20-26. PubMed ID: 30246667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Repeated Ketamine Infusion Over Facial Emotion Recognition in Treatment-Resistant Depression: A Preliminary Report.
    Shiroma PR; Albott CS; Johns B; Thuras P; Wels J; Lim KO
    J Neuropsychiatry Clin Neurosci; 2015; 27(4):362-4. PubMed ID: 25658683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of ketamine.
    Stahl SM
    CNS Spectr; 2013 Aug; 18(4):171-4. PubMed ID: 23866089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder.
    Blier P
    Biol Psychiatry; 2013 Aug; 74(4):238-9. PubMed ID: 23885752
    [No Abstract]   [Full Text] [Related]  

  • 19. All Suicidal Ideation Is Not Created Equal: Two Cases of Suicide Attempts During Maintenance Ketamine Treatment.
    Cusin C; Sakurai H; Bentley K; Pedrelli P; Foster S; Fava M; Mischoulon D
    Am J Psychiatry; 2020 Feb; 177(2):173-174. PubMed ID: 32008389
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.
    Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS
    Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.